| DC Field | Value | Language |
|---|
| dc.contributor.author | Konovalova, E. A. | - |
| dc.contributor.author | Chernomortseva, E. S. | - |
| dc.date.accessioned | 2022-04-24T13:17:09Z | - |
| dc.date.available | 2022-04-24T13:17:09Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Konovalova, E.A. The study of the endothelial protective properties of the L-norvaline combination with mexidol in the simulation of L-NAME-induced NO deficiency / E.A. Konovalova, E.S. Chernomortseva // Research Results in Pharmacology. - 2019. - Vol. 5, № 4.- P. 41-46. - Doi: 10.3897/rrpharmacology.5.38405. - Refer.: p. 46. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46326 | - |
| dc.description.abstract | The endothelium is considered as a target for the prevention and treatment of pathological processes leading to cardiovascular diseases. A combination of L-norvaline at a dose of 10 mg/kg and mexidol at a dose of 60 mg/kg against the background of L-NAME-induced endothelial dysfunction has a pronounced endothelial protective effect. The investigated drugs showed pronounced endothelial protective activity and can be recommended for further pre-clinical studies | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelium | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | mexidol | ru |
| dc.subject | L-norvaline | ru |
| dc.subject | nitric oxide | ru |
| dc.title | The study of the endothelial protective properties of the L-norvaline combination with mexidol in the simulation of L-NAME-induced NO deficiency | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 5, № 4
|
